London – On Wednesday, 27th May, OCT Virtual (https://arena-international.com/octvirtual/) will delve into challenges the clinical trials community is facing as the disruption from COVID-19 continues, offering insights on how to adapt and strive through an unprecedented era. Discover key sessions on retaining CRO, Sponsor and Patient Relationships, efficient Remote Patient Management and more.
Clinical trials are now increasingly needing to adopt new approaches in the current challenges created by the COVID-19 global pandemic. A remote workforce, virtual monitoring and trial hybrids are becoming the norm. Do you have the adaptability to adjust your approaches during these trying times?
Both Sponsors and Pharma companies need to understand the crucial steps once the initial Investigational New Drug (IND) is submitted to the FDA; with specific reference to the first 30 days. Gowri Sukumar, Director CMC & Regulatory Affairs, Iterion Therapeutics will guide us through with her talk ‘Understanding Initial IND’ at Outsourcing in Clinical Trials Virtual.
There’s less than 3 weeks to go until OCT Virtual goes live for over 500 attendees across the world to experience the digital edition of the OCT event series from the safety and comfort of their own homes. With two streams of engaging presentations led by industry experts, attendees will have access to a full day of exclusive content right at their fingertips.
This event will offer a full day of 2 streams with experts from all over the world sharing their unique perspective on managing all stages of Outsourcing in Clinical Trials, free of charge.
Other key takeaways:
- The best approaches to managing and developing CRO, Sponsor and Patient Relationships to improve efficiency and streamline processes
- Remote Patient Engagement: Safely Connecting with Patients to diminish trial disruption and ensure accurate data collection
- How to manage trials remotely: from patient engagement, visits and monitoring looking at the new needs created in outsourcing in clinical trials
About Outsourcing in Clinical Trials – Virtual Experience
Holding a virtual conference enables Arena International to create a secure environment for end users and vendors while delivering on what they have signed up for— a platform enabling knowledge sharing, networking and insights from peers to overcome specific challenges. This is an appropriate format to respond to the current global situation as evolutions are uncertain.
About Arena International
Arena International Events Group (part of GlobalData) welcomes over 10,000 business executives each year who attend over 80 of our events worldwide, they are addressed by over 1,700 industry leaders delivering leading edge content and discussion.
Arena International’s events consistently strive to provide thought-provoking content and unrivalled networking opportunities, which add tangible value to those who attend. With comprehensive learning programmes, wide-ranging exhibitions and extensive networking activities we bring together industries to collaborate and learn. www.arena-international.com
Contact:
Kadin Luong
Digital Marketing Executive
T: +44 (0) 20 7936 6811
E: kadin.luong@arena-international.com